Tanay Tandon

Tanay Tandon

Signal active

Founder & CEO

Bio

Tanay founded Clipped in the summer of 2012 as a high school sophomore. He developed the Natural Language technology, and researched the grammatical analysis patterns for information retrieval. As a debater, Tanay found the process of reading evidence files unnecessarily long. Thus, he began work on a data-mining project to extract the most relevant information. He works day-to-day on the algorithm and further improvements on the technology.

Location

Cupertino, California, United States, North America

Social

Primary Organization

Athelas

Athelas

Founded

2016

Employees

101-250

Industry

Biotechnology, Life Science, Health Care

Jobs history

0

N/A

Board and Advisor Roles

0

N/A

Invest in regions

Profile Resume

Tanay Tandon is the Founder & CEO at Athelas, based in United States, North America. With a background in Biotechnology, Tanay Tandon has a rich history of leadership and innovation. Tanay Tandon studied Bachelor's degree Computer Science @ Stanford University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.

Recommendation from your interest

Arash Ferdowsi

Arash Ferdowsi

Co-Founder

Qasar Younis

Qasar Younis

Co-Founder and CEO

Kunal Shah

Kunal Shah

No designation

James Beshara

James Beshara

Founder

Alagu Periyannan

Alagu Periyannan

No designation

Austen Allred

Austen Allred

Co-Founder & CEO

Investment portfolio

Tanay Tandon has made 2 investments. Their Latest investment was Seed Round - Clinikally on Sep 29, 2023

Number of investment

2

Number of exits

0

Personal investment

2

Annouced DateOrganization NameFunding RoundMoney Raised
Nov 16, 2022
OneSchema OneSchema
Seed Round - OneSchema
6.3M
Sep 29, 2023
Clinikally Clinikally
Seed Round - Clinikally
2.6M

Partner investment

0

There is no partner investment available on this profile

Exits

0

There is no exit available on this Profile

Invest in industries

Recent Activity

There is no recent news or activity for this profile.